Medtronic talks diabetes group’s FDA warning letter, new products, supply chain constraints …
Ali Dianaty, VP of product innovation & operations for Medtronic Diabetes, spoke to MedTech Dive about the warning letter’s impact on product … Read source
Click to rate this post!